REQUEST A DEMO
Total
USD $0.00
Search more companies

Biolane Pharm Irena Chojnacka sp. k. (Poland)

Main Activities: Department Stores
Full name: Biolane Pharm Irena Chojnacka sp. k. Profile Updated: March 12, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Biolane Pharm Irena Chojnacka sp. k. is an enterprise based in Poland. Its main office is in Gdynia. The enterprise currently operates in the Department Stores sector. The enterprise was incorporated on March 07, 2022. From the latest financial highlights, Biolane Pharm Irena Chojnacka sp. k. reported a net sales revenue drop of 1.47% in 2025. Its total assets decreased by 9.81% over the same period. Biolane Pharm Irena Chojnacka sp. k.’s net profit margin decreased by 4.51% in 2025.

Headquarters
Ul. A. Hryniewickiego 6C 41
Gdynia; Pomorskie; Postal Code: 81-340

Contact Details: Purchase the Biolane Pharm Irena Chojnacka sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Biolane Pharm Irena Chojnacka sp. k. report to view the information.
Incorporation Date:
March 07, 2022
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Biolane Pharm Irena Chojnacka sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-1.47%
Total Operating Revenue
-1.47%
Operating Profit
-14.68%
Net Profit/Loss for the Period
-14.7%
Total Assets
-9.81%
Total Equity
-9.61%
Operating Profit Margin
-4.95%
Net Profit Margin
-4.51%
Return on Equity (ROE)
-2.04%
Quick Ratio
-4.11%
Cash Ratio
-4.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?